Eylea (Aflibercept) Improves Vision in Diabetic Macular Edema

Regeneron Pharmaceuticals Inc's Eylea (aflibercept) significantly improved vision in patients with diabetic macular edema (DME) compared to laser surgery in two late-stage clinical trials.
Reuters Health Information

Full Story →